Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccin...

por van Doorn, Eva, Liu, Heng, Ben-Yedidia, Tamar, Hassin, Shimon, Visontai, Ildiko, Norley, Stephen, Frijlink, Henderik W., Hak, Eelko
Publicado 2017